Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 17, 2024

Primary Completion Date

October 10, 2024

Study Completion Date

October 13, 2024

Conditions
Allergic Reaction
Interventions
DRUG

DESF

DESF administered in the sublingual space.

DRUG

Epinephrine Injection

Epinephrine manual injection administered intramuscularly according to the approved prescribing information.

Trial Locations (1)

07094

Frontage Clinical Services, Inc., Secaucus

Sponsors
All Listed Sponsors
lead

Aquestive Therapeutics

INDUSTRY

NCT06527937 - Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome | Biotech Hunter | Biotech Hunter